Bretylium-induced voltage-gated sodium current in human lymphocytes

Biochim Biophys Acta. 1992 Oct 27;1137(2):143-7. doi: 10.1016/0167-4889(92)90195-h.

Abstract

Using the whole-cell variation of the patch-clamp technique it has been determined that 0.25-3 mM bretylium tosylate (BT) exerts a repolarizing effect on partially depolarized human lymphocytes. The repolarizing effect was ouabain (40 microM)-sensitive, and was inhibited by the removal of external Na+ or by the Na(+)-channel-blocker amiloride (10-44 microM), but K(+)-channel-blockers 4-aminopyridine (0.1-5 mM) and quinine (100 microM) had no effect. The drug induced a sodium dependent, amiloride-sensitive transient inward current reaching its maximum value approx. 20-30 s after the administration of BT and lasting for 6-10 min. This current was activated by depolarization within 25 ms at around -42 mV, its inactivation took about 2 s and its reversal potential was +24 +/- 5 mV. An increase in the intracellular sodium concentration (1.8-3.2 mM) has been observed upon the addition of BT by monitoring the SBFI fluorescence of the dye-loaded cells. It has been shown that whole-cell K+ currents are significantly decreased by BT. The existence of voltage and ligand (BT)-gated sodium channels has been postulated in human lymphocytes. These channels are thought to participate in the initiation of membrane repolarization in human lymphocytes, and thereby influence mitogenic or antigen-induced cell-activation processes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bretylium Compounds / pharmacology*
  • Humans
  • In Vitro Techniques
  • Ion Channel Gating*
  • Lymphocytes / drug effects
  • Lymphocytes / metabolism*
  • Membrane Potentials / drug effects
  • Sodium Channels / drug effects
  • Sodium Channels / metabolism*

Substances

  • Bretylium Compounds
  • Sodium Channels
  • bretylium